CJC-1295 / Ipamorelin

Advanced Growth Hormone Optimization Research Blend

CJC-1295 / Ipamorelin is a synergistic two-peptide formulation designed to investigate the body’s natural growth hormone axis through complementary mechanisms. By combining the long-acting Growth Hormone Releasing Hormone (GHRH) analog CJC-1295 with the highly selective Growth Hormone Secretagogue (GHS) Ipamorelin, this advanced blend is widely studied for its potential to support lean body composition, recovery, sleep quality, and healthy aging.

Together, these peptides provide researchers with a comprehensive platform for exploring natural growth hormone pulsatility while maintaining a physiologic pattern of GH release.

Key Research Areas

• Studied for natural growth hormone optimization
• Supports lean muscle development and body recomposition
• Investigated for enhanced recovery and tissue repair
• Explored for improved sleep quality and overnight recovery
• Supports healthy IGF-1 production
• Studied for exercise performance and recovery capacity
• Investigated for fat metabolism and body composition
• Supports healthy aging and longevity research

Mechanism of Action

CJC-1295 is a long-acting GHRH analog that stimulates the pituitary gland to promote endogenous growth hormone release over an extended period.

Ipamorelin is a selective ghrelin receptor agonist that stimulates pulsatile growth hormone secretion with minimal interaction with other hormonal pathways.

Working together, these peptides are investigated for their ability to produce a more robust and physiologic growth hormone response than either peptide alone.

Why Researchers Choose CJC-1295 / Ipamorelin

The combination of CJC-1295 and Ipamorelin has become one of the most widely utilized growth hormone research protocols due to its complementary mechanisms of action. Researchers use this blend to study improvements in recovery, lean muscle development, sleep quality, body composition, and overall metabolic health while supporting the body’s natural GH/IGF-1 axis.

Product Highlights

• Dual-peptide growth hormone optimization blend
• Combines complementary GH-releasing mechanisms
• High-purity lyophilized research-grade formulation
• Third-party tested for identity and purity
• Manufactured under strict quality standards

CJC-1295 / Ipamorelin provides researchers with a comprehensive platform for investigating endogenous growth hormone secretion, recovery, performance, body composition, and healthy aging through synergistic activation of the GH/IGF-1 pathway.

For Research Use Only. Not for human consumption.